Biologics, mRNA therapies, antibody drug conjugates (ADCs), and other next-generation pharmaceuticals are highly effective but also extremely sensitive. Ensuring their stability requires more than suitable primary packaging—it demands intelligent secondary solutions that safeguard against light, oxygen, and extreme temperatures. At Schreiner MediPharm, Corinna Endres, Product Manager Drug Protection, is responsible for label systems designed specifically for these challenges. In this interview, she highlights current demands and emerging innovations in drug protection.
- Today is: